Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 14, 2024

BUY
$11.27 - $13.53 $55,223 - $66,297
4,900 Added 9.25%
57,900 $691,000
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $83,433 - $98,745
-8,700 Reduced 14.1%
53,000 $522,000
Q2 2023

Aug 11, 2023

BUY
$9.02 - $10.29 $478,060 - $545,370
53,000 Added 609.2%
61,700 $615,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $80,040 - $106,662
8,700 New
8,700 $83,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $370,012 - $484,897
25,875 New
25,875 $485,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.